TipHub

2,082.2

+86.61 +4.34%

17 Sept 2026

NSE Listed

Novartis Limited (NOVARTIND)

Volume: 1,53,168Avg Vol 1W: 6,31,831.6Avg Vol 1M: 2,38,207.952W Range:672.252,588.8
Key Ratios
Checked 2h ago
Market Cap₹5,138 Cr
Current Price₹2,082.2
Previous Close₹1,995.59
High / Low (52w)₹2,588.8 / ₹672.25
Volume1,53,168
Avg Vol (1W)6,31,831.6
Avg Vol (1M)2,38,207.9
Stock P/E52.55
Book Value₹331.23
Dividend Yield125%
ROE11.39%
ROA9.99%
Revenue (TTM)₹398 Cr
Revenue Growth
Profit Margin26.38%
Total Debt₹0 Cr
Shares Outstanding2 Cr
Face Value₹5
EPS (TTM)₹39.6
P/B6.28
Debt / Equity0.01
50 DMA₹1,662.4
200 DMA₹1,442.39
Day change+4.34%
Price Chart
2,082.2 209.74% · 1Y
242867222.9L
2026-04-15
2026-09-17

20-day avg volume: 2.4L shares

Pros
  • Pays a dividend yield of 125.0%.
  • Company is almost debt-free.
  • Revenue grew 14% YoY.
Cons
  • Stock trades at a high P/E of 53.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹92 Cr₹87 Cr₹93 Cr₹84 Cr₹88 Cr₹90 Cr₹86 Cr₹91 Cr
EBITDA₹34 Cr₹28 Cr₹36 Cr₹34 Cr₹37 Cr₹33 Cr₹31 Cr₹30 Cr
Net Profit₹26 Cr₹20 Cr₹25 Cr₹29 Cr₹28 Cr₹24 Cr₹16 Cr₹25 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹474 Cr₹414 Cr₹433 Cr₹437 Cr₹397 Cr₹398 Cr
EBITDA₹35 Cr₹48 Cr₹51 Cr₹117 Cr₹124 Cr₹131 Cr
Net Profit₹10 Cr₹21 Cr₹-4 Cr₹103 Cr₹85 Cr₹101 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,078 Cr₹1,002 Cr₹958 Cr₹983 Cr₹925 Cr₹948 Cr
Total Liabilities₹357 Cr₹291 Cr₹266 Cr₹207 Cr₹180 Cr₹163 Cr
Equity₹721 Cr₹711 Cr₹692 Cr₹776 Cr₹745 Cr₹785 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024
Operating₹-34 Cr₹57 Cr₹42 Cr₹75 Cr
Investing₹95 Cr₹87 Cr₹-153 Cr₹33 Cr
Financing₹-37 Cr₹-36 Cr₹-30 Cr₹-121 Cr
Free Cash Flow₹-34 Cr₹57 Cr₹42 Cr₹75 Cr
Shareholding
Promoter 58.68% Institutions 14.98% Public 26.35%
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search